NCT00938977

Brief Summary

Main objective: To describe clinical and functional characteristics of the obese hypoventilating patient; to study the relation between the obesity-hypoventilation syndrome (OHS) and the obstructive sleep apnea hypopnea syndrome (OSAHS). In the second stage of the study, to assess patient response to non-invasive mechanical ventilation (NIV) and continuous positive airway pressure (CPAP), and to identify predictors of unfavourable response to treatment. Methodology:

  • Patients: Patients with obesity degree I-III, with pCO2 awake and at rest \> 45 mmHg, with no underlying pulmonary or neuromuscular lung disease; two control groups, one of non-hypoventilating obese patients and the other of obese patients with OSAHS, will also be studied over the same period.
  • Design: Prospective observational study. In the first stage anthropometric, clinical, functional and metabolic data will be recorded for the obese hypoventilating patients and the two control groups (obese patients without respiratory pathology, and obese patients with OSAHS). In the second stage patients with OHS will be divided into two subgroups: group 1: patients with polysomnography (PSG) suggestive of hypoventilation, in whom NIV treatment will be initiated; group 2: patients with PSG suggestive of OSAHS (apnea-hypopnea index \>15), who will be administered CPAP. Patients will be examined one month and three months after the start of treatment. The same measurements will be carried out as at the beginning of the study, with the exception of the polysomnographic study. Nonetheless, pulse oximetry and arterial gases will be performed on waking. Expected Results: Patients with OHS may be characterized and differentiated from obese patients without associated respiratory pathology on the basis of clinical, functional and metabolic data. There is a group of patients with association between OSAHS and OHS that do not respond to treatment with CPAP, and this unfavorable response can be predicted in advance.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2003

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2006

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

July 13, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 14, 2009

Completed
Last Updated

July 14, 2009

Status Verified

July 1, 2009

Enrollment Period

3 years

First QC Date

July 13, 2009

Last Update Submit

July 13, 2009

Conditions

Keywords

Obesity Hypoventilation syndromecytokinesAdipokinescontinuous positive airway pressurebilevel support ventilationResponse to continuous positive airway pressure

Study Arms (2)

CPAP

ACTIVE COMPARATOR

Response to treatment before/after treatment in patients with OSAS and SOH

Device: CPAP

Bilevel support ventilation

ACTIVE COMPARATOR

Before and after effect of Bilevel support ventilation in patients with SOH without OSA

Device: Bilevel Support Ventilation (Non-Invasive Ventilation)

Interventions

CPAPDEVICE

Before and after effect of treatment with CPAP

CPAP

before/after effect of Bilevel support ventilation

Bilevel support ventilation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obesity degree I-III (Body mass index, BMI \>30 Kg/m2)
  • Stable daytime PCO2 \>45 mmHg.
  • Age \< 75 years
  • Absence of other parenchymal, respiratory or neuromuscular diseases, diseases of the chest wall which may occur concomitantly with hypoventilation.

You may not qualify if:

  • Cognitive disorders that interfere with the administration of the clinical questionnaires.
  • Severe comorbidity.
  • FEV1/FVC ratio \< 65% in the forced spirometry.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, Barcelona, 08025, Spain

Location

Related Publications (1)

  • Salord N, Mayos M, Miralda RM, Farre A, Carreras M, Sust R, Masuet-Aumatell C, Rodriguez J, Perez A. Continuous positive airway pressure in clinically stable patients with mild-to-moderate obesity hypoventilation syndrome and obstructive sleep apnoea. Respirology. 2013 Oct;18(7):1135-42. doi: 10.1111/resp.12131.

MeSH Terms

Conditions

Obesity Hypoventilation Syndrome

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

Sleep Apnea, ObstructiveSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesHypoventilationRespiratory InsufficiencySleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Neus Salord, MD

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    PRINCIPAL INVESTIGATOR
  • Mercedes Mayos, MD

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 13, 2009

First Posted

July 14, 2009

Study Start

June 1, 2003

Primary Completion

June 1, 2006

Last Updated

July 14, 2009

Record last verified: 2009-07

Locations